Lawmakers are ramping up bipartisan efforts to crack down on pharmacy benefit managers (PBM), accusing the industry middlemen of driving up drug costs and putting small and rural pharmacies out of business.
The Senate Finance Committee on July 26 advanced a broad proposal to address a range of PBM issues, including on drug rebates, transparency, and vertical integration. The House Ways and Means Committee also advanced measures intended to bolster oversight of PBMs on Wednesday.
The proposals follow several other bills advanced by key House and Senate committees this year and are aimed at drawing enough bipartisan, bicameral support to ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.